fbpx

Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission

Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.

Click the orange button to the right to learn more about what you can start doing today.

Search Results for: velcade

Multiple Myeloma Chemotherapy- “Energy Draining Side Effects of Velcade, Revlimid

“The good news is that conventional oncology has gotten pretty good at putting myeloma patients into remission. The bad news is achieving remission usually involves a lot of myeloma chemotherapy…

Continue reading

Multiple Myeloma Treatment- CBD w/ Velcade, Darzalex, Kyprolis?

“These results showed that CBD by itself or in synergy with BORT strongly inhibited growth, arrested cell cycle progression and induced MM cells death…” Hi David-  I am a 60 year old

Continue reading

Myeloma Chemotherapy- Glutathione Integrates W/ Velcade

We here show that bortezomib-induced cytotoxicity was completely dampened when cells were supplemented with cysteine or its derivative, glutathione (GSH) Hi Cancer Coach- Have you ever heard of this glutathione

Continue reading

Relapsed Multiple Myeloma- CR from Velcade w/ CBD

“These results showed that CBD by itself or in synergy with BORT strongly inhibited growth, arrested cell cycle progression and induced MM cells death by regulating…” Hello David- I write

Continue reading

Myeloma Chemotherapy-Velcade, Revlimid, Dex- MRD-, STOP!

“Similarly, the rates of undetectable MRD at a threshold of 3 x 10-6 increased from 28.8% after (MM) induction to 42.1% after transplant and 45.2% after consolidation.” According to the article

Continue reading

Velcade, Myeloma Integrative Therapies-

“Our study suggests that EPA and DHA induce selective cytotoxic effects in MM and increase sensitivity to bortezomib (velcade)…Combined curcumin and PS-341 treatment has been reported to enhance

Continue reading

Velcade, Myeloma Induction

“Failure (of the multiple myeloma patient) to respond to a bortezomib-based induction was found to be an independent risk factor for mortality.” When my oncologist prescribed a triplet for

Continue reading

linvoseltamab for Myeloma

linvoseltamab for Myeloma is yet another possible therapy for relapsed/refractory MM patients. Prospective MM patients must remember, however, that this new therapy comes with serious risks. I am a long-term

Continue reading

Myeloma Clinical Trials Misleading

Myeloma clinical trials being misleading  compared to real life outcomes should not come as a surprise to anyone. Numerous studies conclude that “stringent inclusion criteria” gives a false

Continue reading

Transplant-INeligible Multiple Myeloma

All newly diagnosed myeloma patients are prescribed the standard-of-care MM therapy plan. Therefore, there are only two kinds of newly diagnosed multiple myeloma (NDMM) patients in this world. You are

Continue reading

Berenson Myeloma QoL OS

Berenson Myeloma QoL OS- According to the articles linked and excerpted below, Dr. James Berenson, Myeloma specialist, reports the longest average overall survival of MM patients while striving for the

Continue reading

Light Chain Myeloma- Cure V. Control?

Dear Mr. Emerson: Thank God  I have found a site like yours. I suffer from light chain myeloma diagnosed in January 2023. For 10 months I have undergone chemotherapy with Bortezomib, Dexamethasone, Cyclophosphamide

Continue reading